Abstract
On treating the polynuclear chain complex [Cu(L)(H 2O)] n (H 2L is 5-[(2′-carboxyphenyl)azo]-1, 3-dimethylbarbituric acid) with imidazole the complexes [Cu(L)(Him)] 2 ( 1) and [Cu(L)(Him) 2] ( 2) are obtained. The structures of 1 and 2 have been determined by X-ray crystallographic methods. The structure of 1 consists of dinuclear units in which the copper ions are bridged by the barbituric ring. It crystallizes in the monoclinic space group P2 1/ c with cell constants a = 8.654(2), b = 22.64(2), c = 8.8048(8) Å, β = 103.76(1)°, Z = 2, R = 0.051 and R w = 0.041. The structure of 2 consists of discrete [Cu(L)(Him) 2] molecules held together by intermolecular hydrogen bonds to form infinite chains. It crystallizes in the triclinic space group P 1 with cell constants a 8.268(2), b = 9.412(3), c = 13.798(5) Å, α = 99.07(3), β = 91.20(3), γ = 108.64(2)°, Z = 2, R = 0.041 and R w = 0.035. Comparison of the crystal structure of 1 with analogous complexes containing nitrogen heterocyclic ligands reveals that the replacement of imidazole by pyrazole or pyridine leads to very different crystal structures, which has been attributed to the different nature of the nitrogen heterocyclic ligand used in their syntheses. In dmso solution, EPR spectra of both complexes clearly indicate the existence of a monomer-dimer equilibrium.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.